nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CNR2—pancreatic cancer	0.402	0.579	CbGaD
Rimonabant—CNR1—pancreatic cancer	0.292	0.421	CbGaD
Rimonabant—CYP1A2—Dacarbazine—pancreatic cancer	0.0262	0.133	CbGbCtD
Rimonabant—CYP1A2—Tamoxifen—pancreatic cancer	0.0208	0.106	CbGbCtD
Rimonabant—CYP2C9—Tamoxifen—pancreatic cancer	0.0188	0.0952	CbGbCtD
Rimonabant—CYP1A2—Erlotinib—pancreatic cancer	0.0177	0.0899	CbGbCtD
Rimonabant—CYP2D6—Tamoxifen—pancreatic cancer	0.0172	0.0871	CbGbCtD
Rimonabant—CYP1A2—Fluorouracil—pancreatic cancer	0.0153	0.0779	CbGbCtD
Rimonabant—CYP2D6—Erlotinib—pancreatic cancer	0.0146	0.0741	CbGbCtD
Rimonabant—CYP2C9—Fluorouracil—pancreatic cancer	0.0138	0.0702	CbGbCtD
Rimonabant—CYP3A4—Tamoxifen—pancreatic cancer	0.0109	0.0554	CbGbCtD
Rimonabant—CYP3A4—Erlotinib—pancreatic cancer	0.00927	0.0471	CbGbCtD
Rimonabant—CYP3A4—Irinotecan—pancreatic cancer	0.00837	0.0425	CbGbCtD
Rimonabant—CYP2D6—Doxorubicin—pancreatic cancer	0.00719	0.0365	CbGbCtD
Rimonabant—CYP3A4—Docetaxel—pancreatic cancer	0.00614	0.0312	CbGbCtD
Rimonabant—CYP3A4—Sunitinib—pancreatic cancer	0.00611	0.031	CbGbCtD
Rimonabant—CYP3A4—Doxorubicin—pancreatic cancer	0.00457	0.0232	CbGbCtD
Rimonabant—Dry mouth—Tamoxifen—pancreatic cancer	0.000254	0.00436	CcSEcCtD
Rimonabant—Lethargy—Docetaxel—pancreatic cancer	0.000252	0.00433	CcSEcCtD
Rimonabant—Muscle spasms—Sunitinib—pancreatic cancer	0.000251	0.00431	CcSEcCtD
Rimonabant—Sinusitis—Fluorouracil—pancreatic cancer	0.000247	0.00425	CcSEcCtD
Rimonabant—Infection—Tamoxifen—pancreatic cancer	0.000247	0.00424	CcSEcCtD
Rimonabant—Infection—Erlotinib—pancreatic cancer	0.000245	0.0042	CcSEcCtD
Rimonabant—Connective tissue disorder—Irinotecan—pancreatic cancer	0.000243	0.00417	CcSEcCtD
Rimonabant—Nervous system disorder—Erlotinib—pancreatic cancer	0.000241	0.00414	CcSEcCtD
Rimonabant—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.000241	0.00413	CcSEcCtD
Rimonabant—Skin disorder—Erlotinib—pancreatic cancer	0.000239	0.0041	CcSEcCtD
Rimonabant—Anorexia—Tamoxifen—pancreatic cancer	0.000237	0.00407	CcSEcCtD
Rimonabant—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.000236	0.00406	CcSEcCtD
Rimonabant—Hypoaesthesia—Fluorouracil—pancreatic cancer	0.000235	0.00404	CcSEcCtD
Rimonabant—Anorexia—Erlotinib—pancreatic cancer	0.000235	0.00403	CcSEcCtD
Rimonabant—Hiccups—Epirubicin—pancreatic cancer	0.000229	0.00394	CcSEcCtD
Rimonabant—Convulsion—Sunitinib—pancreatic cancer	0.000226	0.00388	CcSEcCtD
Rimonabant—Insomnia—Tamoxifen—pancreatic cancer	0.000225	0.00386	CcSEcCtD
Rimonabant—Angiopathy—Irinotecan—pancreatic cancer	0.000224	0.00385	CcSEcCtD
Rimonabant—Paraesthesia—Tamoxifen—pancreatic cancer	0.000223	0.00384	CcSEcCtD
Rimonabant—Mediastinal disorder—Irinotecan—pancreatic cancer	0.000223	0.00382	CcSEcCtD
Rimonabant—Insomnia—Erlotinib—pancreatic cancer	0.000223	0.00382	CcSEcCtD
Rimonabant—Cramp muscle—Docetaxel—pancreatic cancer	0.000222	0.00382	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000221	0.00379	CcSEcCtD
Rimonabant—Angiopathy—Gemcitabine—pancreatic cancer	0.000218	0.00375	CcSEcCtD
Rimonabant—Dry mouth—Sunitinib—pancreatic cancer	0.000217	0.00373	CcSEcCtD
Rimonabant—Mediastinal disorder—Gemcitabine—pancreatic cancer	0.000217	0.00372	CcSEcCtD
Rimonabant—Decreased appetite—Tamoxifen—pancreatic cancer	0.000216	0.00371	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000215	0.00369	CcSEcCtD
Rimonabant—Fatigue—Tamoxifen—pancreatic cancer	0.000215	0.00368	CcSEcCtD
Rimonabant—Decreased appetite—Erlotinib—pancreatic cancer	0.000214	0.00367	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000213	0.00365	CcSEcCtD
Rimonabant—Hiccups—Doxorubicin—pancreatic cancer	0.000212	0.00364	CcSEcCtD
Rimonabant—Fatigue—Erlotinib—pancreatic cancer	0.000212	0.00364	CcSEcCtD
Rimonabant—Infection—Sunitinib—pancreatic cancer	0.000212	0.00363	CcSEcCtD
Rimonabant—Nervous system disorder—Sunitinib—pancreatic cancer	0.000209	0.00359	CcSEcCtD
Rimonabant—Skin disorder—Sunitinib—pancreatic cancer	0.000207	0.00355	CcSEcCtD
Rimonabant—Muscle spasms—Irinotecan—pancreatic cancer	0.000207	0.00355	CcSEcCtD
Rimonabant—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000203	0.00349	CcSEcCtD
Rimonabant—Anorexia—Sunitinib—pancreatic cancer	0.000203	0.00349	CcSEcCtD
Rimonabant—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000201	0.00346	CcSEcCtD
Rimonabant—Abdominal pain—Tamoxifen—pancreatic cancer	0.000197	0.00338	CcSEcCtD
Rimonabant—Abdominal pain—Erlotinib—pancreatic cancer	0.000195	0.00334	CcSEcCtD
Rimonabant—Insomnia—Sunitinib—pancreatic cancer	0.000193	0.00331	CcSEcCtD
Rimonabant—Paraesthesia—Sunitinib—pancreatic cancer	0.000191	0.00329	CcSEcCtD
Rimonabant—Infestation NOS—Docetaxel—pancreatic cancer	0.00019	0.00327	CcSEcCtD
Rimonabant—Infestation—Docetaxel—pancreatic cancer	0.00019	0.00327	CcSEcCtD
Rimonabant—Decreased appetite—Sunitinib—pancreatic cancer	0.000185	0.00318	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000184	0.00316	CcSEcCtD
Rimonabant—Fatigue—Sunitinib—pancreatic cancer	0.000184	0.00315	CcSEcCtD
Rimonabant—Asthenia—Tamoxifen—pancreatic cancer	0.000179	0.00306	CcSEcCtD
Rimonabant—Convulsion—Fluorouracil—pancreatic cancer	0.000178	0.00306	CcSEcCtD
Rimonabant—Hot flush—Epirubicin—pancreatic cancer	0.000178	0.00306	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000177	0.00304	CcSEcCtD
Rimonabant—Asthenia—Erlotinib—pancreatic cancer	0.000177	0.00303	CcSEcCtD
Rimonabant—Menopausal symptoms—Epirubicin—pancreatic cancer	0.000176	0.00303	CcSEcCtD
Rimonabant—Pruritus—Tamoxifen—pancreatic cancer	0.000176	0.00302	CcSEcCtD
Rimonabant—Infection—Irinotecan—pancreatic cancer	0.000174	0.00299	CcSEcCtD
Rimonabant—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000174	0.00299	CcSEcCtD
Rimonabant—Pruritus—Erlotinib—pancreatic cancer	0.000174	0.00299	CcSEcCtD
Rimonabant—Nervous system disorder—Irinotecan—pancreatic cancer	0.000172	0.00296	CcSEcCtD
Rimonabant—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000171	0.00293	CcSEcCtD
Rimonabant—Diarrhoea—Tamoxifen—pancreatic cancer	0.00017	0.00292	CcSEcCtD
Rimonabant—Hypoaesthesia—Docetaxel—pancreatic cancer	0.00017	0.00292	CcSEcCtD
Rimonabant—Lethargy—Epirubicin—pancreatic cancer	0.00017	0.00292	CcSEcCtD
Rimonabant—Infection—Gemcitabine—pancreatic cancer	0.00017	0.00292	CcSEcCtD
Rimonabant—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00017	0.00291	CcSEcCtD
Rimonabant—Abdominal pain—Sunitinib—pancreatic cancer	0.000168	0.00289	CcSEcCtD
Rimonabant—Diarrhoea—Erlotinib—pancreatic cancer	0.000168	0.00289	CcSEcCtD
Rimonabant—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000168	0.00288	CcSEcCtD
Rimonabant—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000168	0.00288	CcSEcCtD
Rimonabant—Anorexia—Irinotecan—pancreatic cancer	0.000167	0.00287	CcSEcCtD
Rimonabant—Infection—Fluorouracil—pancreatic cancer	0.000167	0.00287	CcSEcCtD
Rimonabant—Skin disorder—Gemcitabine—pancreatic cancer	0.000166	0.00285	CcSEcCtD
Rimonabant—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000165	0.00284	CcSEcCtD
Rimonabant—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000165	0.00283	CcSEcCtD
Rimonabant—Hot flush—Doxorubicin—pancreatic cancer	0.000165	0.00283	CcSEcCtD
Rimonabant—Dizziness—Tamoxifen—pancreatic cancer	0.000165	0.00282	CcSEcCtD
Rimonabant—Menopausal symptoms—Doxorubicin—pancreatic cancer	0.000163	0.0028	CcSEcCtD
Rimonabant—Anorexia—Gemcitabine—pancreatic cancer	0.000163	0.0028	CcSEcCtD
Rimonabant—Dizziness—Erlotinib—pancreatic cancer	0.000163	0.00279	CcSEcCtD
Rimonabant—Anorexia—Fluorouracil—pancreatic cancer	0.00016	0.00275	CcSEcCtD
Rimonabant—Insomnia—Irinotecan—pancreatic cancer	0.000159	0.00273	CcSEcCtD
Rimonabant—Vomiting—Tamoxifen—pancreatic cancer	0.000158	0.00272	CcSEcCtD
Rimonabant—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.000158	0.00271	CcSEcCtD
Rimonabant—Mood swings—Epirubicin—pancreatic cancer	0.000158	0.00271	CcSEcCtD
Rimonabant—Paraesthesia—Irinotecan—pancreatic cancer	0.000158	0.00271	CcSEcCtD
Rimonabant—Lethargy—Doxorubicin—pancreatic cancer	0.000157	0.0027	CcSEcCtD
Rimonabant—Rash—Tamoxifen—pancreatic cancer	0.000157	0.00269	CcSEcCtD
Rimonabant—Dermatitis—Tamoxifen—pancreatic cancer	0.000157	0.00269	CcSEcCtD
Rimonabant—Vomiting—Erlotinib—pancreatic cancer	0.000157	0.00269	CcSEcCtD
Rimonabant—Headache—Tamoxifen—pancreatic cancer	0.000156	0.00268	CcSEcCtD
Rimonabant—Rash—Erlotinib—pancreatic cancer	0.000155	0.00266	CcSEcCtD
Rimonabant—Dermatitis—Erlotinib—pancreatic cancer	0.000155	0.00266	CcSEcCtD
Rimonabant—Angiopathy—Docetaxel—pancreatic cancer	0.000155	0.00266	CcSEcCtD
Rimonabant—Insomnia—Gemcitabine—pancreatic cancer	0.000155	0.00266	CcSEcCtD
Rimonabant—Headache—Erlotinib—pancreatic cancer	0.000154	0.00265	CcSEcCtD
Rimonabant—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000154	0.00264	CcSEcCtD
Rimonabant—Paraesthesia—Gemcitabine—pancreatic cancer	0.000154	0.00264	CcSEcCtD
Rimonabant—Asthenia—Sunitinib—pancreatic cancer	0.000153	0.00262	CcSEcCtD
Rimonabant—Decreased appetite—Irinotecan—pancreatic cancer	0.000153	0.00262	CcSEcCtD
Rimonabant—Insomnia—Fluorouracil—pancreatic cancer	0.000152	0.00261	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000152	0.0026	CcSEcCtD
Rimonabant—Fatigue—Irinotecan—pancreatic cancer	0.000151	0.0026	CcSEcCtD
Rimonabant—Paraesthesia—Fluorouracil—pancreatic cancer	0.000151	0.00259	CcSEcCtD
Rimonabant—Pruritus—Sunitinib—pancreatic cancer	0.000151	0.00259	CcSEcCtD
Rimonabant—Mental disorder—Docetaxel—pancreatic cancer	0.00015	0.00257	CcSEcCtD
Rimonabant—Malnutrition—Docetaxel—pancreatic cancer	0.000149	0.00255	CcSEcCtD
Rimonabant—Decreased appetite—Gemcitabine—pancreatic cancer	0.000149	0.00255	CcSEcCtD
Rimonabant—Nausea—Tamoxifen—pancreatic cancer	0.000148	0.00254	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000148	0.00253	CcSEcCtD
Rimonabant—Fatigue—Gemcitabine—pancreatic cancer	0.000147	0.00253	CcSEcCtD
Rimonabant—Nausea—Erlotinib—pancreatic cancer	0.000146	0.00251	CcSEcCtD
Rimonabant—Decreased appetite—Fluorouracil—pancreatic cancer	0.000146	0.00251	CcSEcCtD
Rimonabant—Mood swings—Doxorubicin—pancreatic cancer	0.000146	0.00251	CcSEcCtD
Rimonabant—Diarrhoea—Sunitinib—pancreatic cancer	0.000146	0.0025	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000145	0.00249	CcSEcCtD
Rimonabant—Influenza—Epirubicin—pancreatic cancer	0.000144	0.00247	CcSEcCtD
Rimonabant—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000144	0.00246	CcSEcCtD
Rimonabant—Muscle spasms—Docetaxel—pancreatic cancer	0.000143	0.00245	CcSEcCtD
Rimonabant—Dizziness—Sunitinib—pancreatic cancer	0.000141	0.00242	CcSEcCtD
Rimonabant—Abdominal pain—Irinotecan—pancreatic cancer	0.000139	0.00238	CcSEcCtD
Rimonabant—Vomiting—Sunitinib—pancreatic cancer	0.000135	0.00233	CcSEcCtD
Rimonabant—Rash—Sunitinib—pancreatic cancer	0.000134	0.00231	CcSEcCtD
Rimonabant—Dermatitis—Sunitinib—pancreatic cancer	0.000134	0.0023	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000134	0.0023	CcSEcCtD
Rimonabant—Headache—Sunitinib—pancreatic cancer	0.000133	0.00229	CcSEcCtD
Rimonabant—Influenza—Doxorubicin—pancreatic cancer	0.000133	0.00229	CcSEcCtD
Rimonabant—Convulsion—Docetaxel—pancreatic cancer	0.000129	0.00221	CcSEcCtD
Rimonabant—Infestation NOS—Epirubicin—pancreatic cancer	0.000128	0.0022	CcSEcCtD
Rimonabant—Infestation—Epirubicin—pancreatic cancer	0.000128	0.0022	CcSEcCtD
Rimonabant—Nausea—Sunitinib—pancreatic cancer	0.000127	0.00217	CcSEcCtD
Rimonabant—Asthenia—Irinotecan—pancreatic cancer	0.000126	0.00216	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000126	0.00216	CcSEcCtD
Rimonabant—Dry mouth—Docetaxel—pancreatic cancer	0.000124	0.00213	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000124	0.00212	CcSEcCtD
Rimonabant—Asthenia—Gemcitabine—pancreatic cancer	0.000123	0.00211	CcSEcCtD
Rimonabant—Pruritus—Gemcitabine—pancreatic cancer	0.000121	0.00208	CcSEcCtD
Rimonabant—Infection—Docetaxel—pancreatic cancer	0.000121	0.00207	CcSEcCtD
Rimonabant—Sinusitis—Epirubicin—pancreatic cancer	0.00012	0.00207	CcSEcCtD
Rimonabant—Diarrhoea—Irinotecan—pancreatic cancer	0.00012	0.00206	CcSEcCtD
Rimonabant—Nervous system disorder—Docetaxel—pancreatic cancer	0.000119	0.00204	CcSEcCtD
Rimonabant—Pruritus—Fluorouracil—pancreatic cancer	0.000119	0.00204	CcSEcCtD
Rimonabant—Infestation NOS—Doxorubicin—pancreatic cancer	0.000119	0.00204	CcSEcCtD
Rimonabant—Infestation—Doxorubicin—pancreatic cancer	0.000119	0.00204	CcSEcCtD
Rimonabant—Skin disorder—Docetaxel—pancreatic cancer	0.000118	0.00202	CcSEcCtD
Rimonabant—Diarrhoea—Gemcitabine—pancreatic cancer	0.000117	0.00201	CcSEcCtD
Rimonabant—Dizziness—Irinotecan—pancreatic cancer	0.000116	0.00199	CcSEcCtD
Rimonabant—Anorexia—Docetaxel—pancreatic cancer	0.000116	0.00199	CcSEcCtD
Rimonabant—Diarrhoea—Fluorouracil—pancreatic cancer	0.000115	0.00197	CcSEcCtD
Rimonabant—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000115	0.00197	CcSEcCtD
Rimonabant—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000113	0.00194	CcSEcCtD
Rimonabant—Vomiting—Irinotecan—pancreatic cancer	0.000112	0.00192	CcSEcCtD
Rimonabant—Sinusitis—Doxorubicin—pancreatic cancer	0.000111	0.00191	CcSEcCtD
Rimonabant—Dizziness—Fluorouracil—pancreatic cancer	0.000111	0.00191	CcSEcCtD
Rimonabant—Rash—Irinotecan—pancreatic cancer	0.000111	0.0019	CcSEcCtD
Rimonabant—Dermatitis—Irinotecan—pancreatic cancer	0.000111	0.0019	CcSEcCtD
Rimonabant—Headache—Irinotecan—pancreatic cancer	0.00011	0.00189	CcSEcCtD
Rimonabant—Insomnia—Docetaxel—pancreatic cancer	0.00011	0.00188	CcSEcCtD
Rimonabant—Paraesthesia—Docetaxel—pancreatic cancer	0.000109	0.00187	CcSEcCtD
Rimonabant—Vomiting—Gemcitabine—pancreatic cancer	0.000109	0.00187	CcSEcCtD
Rimonabant—Rash—Gemcitabine—pancreatic cancer	0.000108	0.00185	CcSEcCtD
Rimonabant—Dermatitis—Gemcitabine—pancreatic cancer	0.000108	0.00185	CcSEcCtD
Rimonabant—Headache—Gemcitabine—pancreatic cancer	0.000107	0.00184	CcSEcCtD
Rimonabant—Vomiting—Fluorouracil—pancreatic cancer	0.000107	0.00184	CcSEcCtD
Rimonabant—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000106	0.00182	CcSEcCtD
Rimonabant—Rash—Fluorouracil—pancreatic cancer	0.000106	0.00182	CcSEcCtD
Rimonabant—Dermatitis—Fluorouracil—pancreatic cancer	0.000106	0.00182	CcSEcCtD
Rimonabant—Decreased appetite—Docetaxel—pancreatic cancer	0.000105	0.00181	CcSEcCtD
Rimonabant—Headache—Fluorouracil—pancreatic cancer	0.000105	0.00181	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000105	0.0018	CcSEcCtD
Rimonabant—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000105	0.0018	CcSEcCtD
Rimonabant—Fatigue—Docetaxel—pancreatic cancer	0.000105	0.0018	CcSEcCtD
Rimonabant—Angiopathy—Epirubicin—pancreatic cancer	0.000105	0.00179	CcSEcCtD
Rimonabant—Nausea—Irinotecan—pancreatic cancer	0.000104	0.00179	CcSEcCtD
Rimonabant—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000104	0.00178	CcSEcCtD
Rimonabant—Nausea—Gemcitabine—pancreatic cancer	0.000102	0.00174	CcSEcCtD
Rimonabant—Mental disorder—Epirubicin—pancreatic cancer	0.000101	0.00173	CcSEcCtD
Rimonabant—Malnutrition—Epirubicin—pancreatic cancer	0.0001	0.00172	CcSEcCtD
Rimonabant—Nausea—Fluorouracil—pancreatic cancer	9.99e-05	0.00171	CcSEcCtD
Rimonabant—Gastrointestinal pain—Docetaxel—pancreatic cancer	9.92e-05	0.0017	CcSEcCtD
Rimonabant—Tension—Epirubicin—pancreatic cancer	9.84e-05	0.00169	CcSEcCtD
Rimonabant—Nervousness—Epirubicin—pancreatic cancer	9.74e-05	0.00167	CcSEcCtD
Rimonabant—Angiopathy—Doxorubicin—pancreatic cancer	9.67e-05	0.00166	CcSEcCtD
Rimonabant—Muscle spasms—Epirubicin—pancreatic cancer	9.64e-05	0.00166	CcSEcCtD
Rimonabant—Mediastinal disorder—Doxorubicin—pancreatic cancer	9.61e-05	0.00165	CcSEcCtD
Rimonabant—Abdominal pain—Docetaxel—pancreatic cancer	9.59e-05	0.00165	CcSEcCtD
Rimonabant—Mental disorder—Doxorubicin—pancreatic cancer	9.34e-05	0.0016	CcSEcCtD
Rimonabant—Malnutrition—Doxorubicin—pancreatic cancer	9.28e-05	0.00159	CcSEcCtD
Rimonabant—Tension—Doxorubicin—pancreatic cancer	9.11e-05	0.00156	CcSEcCtD
Rimonabant—Nervousness—Doxorubicin—pancreatic cancer	9.01e-05	0.00155	CcSEcCtD
Rimonabant—Muscle spasms—Doxorubicin—pancreatic cancer	8.92e-05	0.00153	CcSEcCtD
Rimonabant—Asthenia—Docetaxel—pancreatic cancer	8.71e-05	0.00149	CcSEcCtD
Rimonabant—Convulsion—Epirubicin—pancreatic cancer	8.69e-05	0.00149	CcSEcCtD
Rimonabant—Pruritus—Docetaxel—pancreatic cancer	8.58e-05	0.00147	CcSEcCtD
Rimonabant—Anxiety—Epirubicin—pancreatic cancer	8.51e-05	0.00146	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	8.48e-05	0.00146	CcSEcCtD
Rimonabant—Dry mouth—Epirubicin—pancreatic cancer	8.35e-05	0.00143	CcSEcCtD
Rimonabant—Diarrhoea—Docetaxel—pancreatic cancer	8.3e-05	0.00143	CcSEcCtD
Rimonabant—Infection—Epirubicin—pancreatic cancer	8.13e-05	0.0014	CcSEcCtD
Rimonabant—Convulsion—Doxorubicin—pancreatic cancer	8.04e-05	0.00138	CcSEcCtD
Rimonabant—Nervous system disorder—Epirubicin—pancreatic cancer	8.03e-05	0.00138	CcSEcCtD
Rimonabant—Dizziness—Docetaxel—pancreatic cancer	8.02e-05	0.00138	CcSEcCtD
Rimonabant—Skin disorder—Epirubicin—pancreatic cancer	7.95e-05	0.00136	CcSEcCtD
Rimonabant—Hyperhidrosis—Epirubicin—pancreatic cancer	7.91e-05	0.00136	CcSEcCtD
Rimonabant—Anxiety—Doxorubicin—pancreatic cancer	7.87e-05	0.00135	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	7.85e-05	0.00135	CcSEcCtD
Rimonabant—Anorexia—Epirubicin—pancreatic cancer	7.8e-05	0.00134	CcSEcCtD
Rimonabant—Dry mouth—Doxorubicin—pancreatic cancer	7.73e-05	0.00133	CcSEcCtD
Rimonabant—Vomiting—Docetaxel—pancreatic cancer	7.71e-05	0.00132	CcSEcCtD
Rimonabant—Rash—Docetaxel—pancreatic cancer	7.65e-05	0.00131	CcSEcCtD
Rimonabant—Dermatitis—Docetaxel—pancreatic cancer	7.64e-05	0.00131	CcSEcCtD
Rimonabant—Headache—Docetaxel—pancreatic cancer	7.6e-05	0.00131	CcSEcCtD
Rimonabant—Infection—Doxorubicin—pancreatic cancer	7.52e-05	0.00129	CcSEcCtD
Rimonabant—Nervous system disorder—Doxorubicin—pancreatic cancer	7.43e-05	0.00127	CcSEcCtD
Rimonabant—Insomnia—Epirubicin—pancreatic cancer	7.4e-05	0.00127	CcSEcCtD
Rimonabant—Skin disorder—Doxorubicin—pancreatic cancer	7.36e-05	0.00126	CcSEcCtD
Rimonabant—Paraesthesia—Epirubicin—pancreatic cancer	7.35e-05	0.00126	CcSEcCtD
Rimonabant—Hyperhidrosis—Doxorubicin—pancreatic cancer	7.32e-05	0.00126	CcSEcCtD
Rimonabant—Anorexia—Doxorubicin—pancreatic cancer	7.22e-05	0.00124	CcSEcCtD
Rimonabant—Nausea—Docetaxel—pancreatic cancer	7.21e-05	0.00124	CcSEcCtD
Rimonabant—Decreased appetite—Epirubicin—pancreatic cancer	7.11e-05	0.00122	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Epirubicin—pancreatic cancer	7.07e-05	0.00121	CcSEcCtD
Rimonabant—Fatigue—Epirubicin—pancreatic cancer	7.06e-05	0.00121	CcSEcCtD
Rimonabant—Insomnia—Doxorubicin—pancreatic cancer	6.85e-05	0.00118	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—GLP1R—pancreatic cancer	6.83e-05	0.00133	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—CXCL8—pancreatic cancer	6.83e-05	0.00133	CbGpPWpGaD
Rimonabant—Paraesthesia—Doxorubicin—pancreatic cancer	6.8e-05	0.00117	CcSEcCtD
Rimonabant—CNR1—BDNF signaling pathway—AKT1—pancreatic cancer	6.79e-05	0.00132	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CCKAR—pancreatic cancer	6.72e-05	0.00131	CbGpPWpGaD
Rimonabant—Gastrointestinal pain—Epirubicin—pancreatic cancer	6.69e-05	0.00115	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—GLI1—pancreatic cancer	6.65e-05	0.0013	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—DTX4—pancreatic cancer	6.65e-05	0.0013	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—AGTR1—pancreatic cancer	6.61e-05	0.00129	CbGpPWpGaD
Rimonabant—Decreased appetite—Doxorubicin—pancreatic cancer	6.58e-05	0.00113	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	6.54e-05	0.00112	CcSEcCtD
Rimonabant—Fatigue—Doxorubicin—pancreatic cancer	6.53e-05	0.00112	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—JAG2—pancreatic cancer	6.52e-05	0.00127	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NRP1—pancreatic cancer	6.47e-05	0.00126	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PPP2R5B—pancreatic cancer	6.47e-05	0.00126	CbGpPWpGaD
Rimonabant—Abdominal pain—Epirubicin—pancreatic cancer	6.47e-05	0.00111	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—MEN1—pancreatic cancer	6.42e-05	0.00125	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—GCG—pancreatic cancer	6.29e-05	0.00123	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HEY2—pancreatic cancer	6.23e-05	0.00121	CbGpPWpGaD
Rimonabant—Gastrointestinal pain—Doxorubicin—pancreatic cancer	6.19e-05	0.00106	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—SHH—pancreatic cancer	6.13e-05	0.0012	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NOTCH4—pancreatic cancer	6.09e-05	0.00119	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—GAST—pancreatic cancer	6.08e-05	0.00119	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IAPP—pancreatic cancer	6.05e-05	0.00118	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—AGTR1—pancreatic cancer	6e-05	0.00117	CbGpPWpGaD
Rimonabant—Abdominal pain—Doxorubicin—pancreatic cancer	5.99e-05	0.00103	CcSEcCtD
Rimonabant—Asthenia—Epirubicin—pancreatic cancer	5.87e-05	0.00101	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—PTHLH—pancreatic cancer	5.81e-05	0.00113	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PTCH1—pancreatic cancer	5.81e-05	0.00113	CbGpPWpGaD
Rimonabant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	5.8e-05	0.00113	CbGpPWpGaD
Rimonabant—Pruritus—Epirubicin—pancreatic cancer	5.79e-05	0.000994	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—SCT—pancreatic cancer	5.77e-05	0.00112	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HEY1—pancreatic cancer	5.77e-05	0.00112	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	5.65e-05	0.0011	CbGpPWpGaD
Rimonabant—Diarrhoea—Epirubicin—pancreatic cancer	5.6e-05	0.000961	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—CCK—pancreatic cancer	5.5e-05	0.00107	CbGpPWpGaD
Rimonabant—Asthenia—Doxorubicin—pancreatic cancer	5.43e-05	0.000933	CcSEcCtD
Rimonabant—Dizziness—Epirubicin—pancreatic cancer	5.41e-05	0.000929	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—CNR2—pancreatic cancer	5.36e-05	0.00105	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—GLP1R—pancreatic cancer	5.36e-05	0.00105	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—CXCL8—pancreatic cancer	5.36e-05	0.00105	CbGpPWpGaD
Rimonabant—Pruritus—Doxorubicin—pancreatic cancer	5.36e-05	0.00092	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—SST—pancreatic cancer	5.31e-05	0.00104	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCKAR—pancreatic cancer	5.28e-05	0.00103	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—PIK3CG—pancreatic cancer	5.24e-05	0.00102	CbGpPWpGaD
Rimonabant—Vomiting—Epirubicin—pancreatic cancer	5.2e-05	0.000893	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—JAG1—pancreatic cancer	5.2e-05	0.00101	CbGpPWpGaD
Rimonabant—Diarrhoea—Doxorubicin—pancreatic cancer	5.18e-05	0.00089	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—NOTCH3—pancreatic cancer	5.18e-05	0.00101	CbGpPWpGaD
Rimonabant—Rash—Epirubicin—pancreatic cancer	5.16e-05	0.000886	CcSEcCtD
Rimonabant—Dermatitis—Epirubicin—pancreatic cancer	5.16e-05	0.000885	CcSEcCtD
Rimonabant—Headache—Epirubicin—pancreatic cancer	5.13e-05	0.00088	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—JAG2—pancreatic cancer	5.12e-05	0.000998	CbGpPWpGaD
Rimonabant—CYP2C9—Arachidonic acid metabolism—PTGS2—pancreatic cancer	5.09e-05	0.000992	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MEN1—pancreatic cancer	5.04e-05	0.000983	CbGpPWpGaD
Rimonabant—Dizziness—Doxorubicin—pancreatic cancer	5.01e-05	0.00086	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—CNR1—pancreatic cancer	4.9e-05	0.000956	CbGpPWpGaD
Rimonabant—Nausea—Epirubicin—pancreatic cancer	4.86e-05	0.000835	CcSEcCtD
Rimonabant—Vomiting—Doxorubicin—pancreatic cancer	4.81e-05	0.000827	CcSEcCtD
Rimonabant—CNR1—Signaling Pathways—SHH—pancreatic cancer	4.81e-05	0.000938	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NOTCH4—pancreatic cancer	4.78e-05	0.000932	CbGpPWpGaD
Rimonabant—Rash—Doxorubicin—pancreatic cancer	4.77e-05	0.00082	CcSEcCtD
Rimonabant—Dermatitis—Doxorubicin—pancreatic cancer	4.77e-05	0.000819	CcSEcCtD
Rimonabant—CNR2—Signaling by GPCR—PIK3CG—pancreatic cancer	4.76e-05	0.000928	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IAPP—pancreatic cancer	4.75e-05	0.000926	CbGpPWpGaD
Rimonabant—Headache—Doxorubicin—pancreatic cancer	4.74e-05	0.000814	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—GCG—pancreatic cancer	4.74e-05	0.000924	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	4.65e-05	0.000906	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—PIK3CD—pancreatic cancer	4.61e-05	0.000899	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PTHLH—pancreatic cancer	4.56e-05	0.000889	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PTCH1—pancreatic cancer	4.56e-05	0.000889	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—AGTR1—pancreatic cancer	4.52e-05	0.000881	CbGpPWpGaD
Rimonabant—Nausea—Doxorubicin—pancreatic cancer	4.5e-05	0.000772	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—STK11—pancreatic cancer	4.45e-05	0.000869	CbGpPWpGaD
Rimonabant—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatic cancer	4.35e-05	0.000848	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—PIK3CD—pancreatic cancer	4.18e-05	0.000816	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—SST—pancreatic cancer	4.17e-05	0.000813	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—PIK3CG—pancreatic cancer	4.11e-05	0.000802	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—JAG1—pancreatic cancer	4.08e-05	0.000796	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NOTCH3—pancreatic cancer	4.06e-05	0.000793	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.02e-05	0.000783	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—SMAD4—pancreatic cancer	3.9e-05	0.000761	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—CXCL8—pancreatic cancer	3.86e-05	0.000753	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HES1—pancreatic cancer	3.81e-05	0.000743	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	3.76e-05	0.000733	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	3.76e-05	0.000733	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PIK3CG—pancreatic cancer	3.73e-05	0.000728	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—GCG—pancreatic cancer	3.72e-05	0.000725	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	3.66e-05	0.000714	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—PIK3CB—pancreatic cancer	3.65e-05	0.000711	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.62e-05	0.000705	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	3.61e-05	0.000705	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—AGTR1—pancreatic cancer	3.55e-05	0.000692	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—CXCL8—pancreatic cancer	3.5e-05	0.000684	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—STK11—pancreatic cancer	3.49e-05	0.000682	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	3.37e-05	0.000657	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	3.36e-05	0.000655	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TERT—pancreatic cancer	3.34e-05	0.000651	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	3.29e-05	0.000642	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	3.29e-05	0.000642	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PIK3CD—pancreatic cancer	3.28e-05	0.00064	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HIF1A—pancreatic cancer	3.19e-05	0.000622	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TSC2—pancreatic cancer	3.18e-05	0.000621	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.15e-05	0.000615	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	3.14e-05	0.000612	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	3.14e-05	0.000612	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—APOE—pancreatic cancer	3.12e-05	0.000608	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	3.11e-05	0.000607	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—SMAD4—pancreatic cancer	3.06e-05	0.000597	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—KDR—pancreatic cancer	3.05e-05	0.000595	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—CXCL8—pancreatic cancer	3.03e-05	0.000591	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HES1—pancreatic cancer	2.99e-05	0.000583	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NFKBIA—pancreatic cancer	2.9e-05	0.000566	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NOTCH1—pancreatic cancer	2.88e-05	0.000561	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.86e-05	0.000558	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PIK3CG—pancreatic cancer	2.81e-05	0.000548	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—NRAS—pancreatic cancer	2.81e-05	0.000548	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—EGF—pancreatic cancer	2.78e-05	0.000542	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CXCL8—pancreatic cancer	2.75e-05	0.000536	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	2.64e-05	0.000516	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TERT—pancreatic cancer	2.62e-05	0.000511	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—EGFR—pancreatic cancer	2.56e-05	0.0005	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HIF1A—pancreatic cancer	2.5e-05	0.000488	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TSC2—pancreatic cancer	2.5e-05	0.000487	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PIK3CD—pancreatic cancer	2.47e-05	0.000482	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.45e-05	0.000477	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—APOE—pancreatic cancer	2.44e-05	0.000477	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—KRAS—pancreatic cancer	2.42e-05	0.000472	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—KDR—pancreatic cancer	2.4e-05	0.000467	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NFKBIA—pancreatic cancer	2.28e-05	0.000444	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NOTCH1—pancreatic cancer	2.26e-05	0.00044	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—PIK3CA—pancreatic cancer	2.22e-05	0.000434	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CG—pancreatic cancer	2.21e-05	0.00043	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—NRAS—pancreatic cancer	2.21e-05	0.00043	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—EGF—pancreatic cancer	2.18e-05	0.000425	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PIK3CB—pancreatic cancer	2.15e-05	0.00042	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CXCL8—pancreatic cancer	2.07e-05	0.000404	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—HRAS—pancreatic cancer	2.06e-05	0.000401	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—EGFR—pancreatic cancer	2.01e-05	0.000392	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—AKT1—pancreatic cancer	2e-05	0.00039	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CASP3—pancreatic cancer	1.98e-05	0.000386	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CD—pancreatic cancer	1.94e-05	0.000378	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CCND1—pancreatic cancer	1.93e-05	0.000376	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.92e-05	0.000375	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CTNNB1—pancreatic cancer	1.91e-05	0.000373	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—KRAS—pancreatic cancer	1.9e-05	0.00037	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MMP9—pancreatic cancer	1.87e-05	0.000365	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PTEN—pancreatic cancer	1.86e-05	0.000363	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—AKT1—pancreatic cancer	1.82e-05	0.000354	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.74e-05	0.00034	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—SRC—pancreatic cancer	1.73e-05	0.000337	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PRSS1—pancreatic cancer	1.71e-05	0.000334	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PRSS1—pancreatic cancer	1.7e-05	0.000331	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CB—pancreatic cancer	1.69e-05	0.00033	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—VEGFA—pancreatic cancer	1.68e-05	0.000328	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—STAT3—pancreatic cancer	1.66e-05	0.000325	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NRAS—pancreatic cancer	1.66e-05	0.000324	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CXCL8—pancreatic cancer	1.62e-05	0.000317	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—HRAS—pancreatic cancer	1.61e-05	0.000315	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—AKT1—pancreatic cancer	1.57e-05	0.000306	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CASP3—pancreatic cancer	1.55e-05	0.000303	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MYC—pancreatic cancer	1.55e-05	0.000302	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TGFB1—pancreatic cancer	1.54e-05	0.000301	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CCND1—pancreatic cancer	1.51e-05	0.000295	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—EGFR—pancreatic cancer	1.51e-05	0.000295	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CTNNB1—pancreatic cancer	1.5e-05	0.000292	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ARG2—pancreatic cancer	1.48e-05	0.000289	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ARG2—pancreatic cancer	1.47e-05	0.000287	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MMP9—pancreatic cancer	1.47e-05	0.000287	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PTEN—pancreatic cancer	1.46e-05	0.000285	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PRSS1—pancreatic cancer	1.45e-05	0.000283	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—KRAS—pancreatic cancer	1.43e-05	0.000279	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—AKT1—pancreatic cancer	1.43e-05	0.000278	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—SRC—pancreatic cancer	1.35e-05	0.000264	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—VEGFA—pancreatic cancer	1.32e-05	0.000257	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PIK3CA—pancreatic cancer	1.31e-05	0.000256	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—STAT3—pancreatic cancer	1.31e-05	0.000255	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NRAS—pancreatic cancer	1.3e-05	0.000254	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—TYMP—pancreatic cancer	1.3e-05	0.000253	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.29e-05	0.000251	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TP53—pancreatic cancer	1.27e-05	0.000248	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ARG2—pancreatic cancer	1.26e-05	0.000245	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—HRAS—pancreatic cancer	1.22e-05	0.000237	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MYC—pancreatic cancer	1.21e-05	0.000237	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TGFB1—pancreatic cancer	1.21e-05	0.000236	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—EGFR—pancreatic cancer	1.19e-05	0.000232	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—KRAS—pancreatic cancer	1.12e-05	0.000219	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.12e-05	0.000218	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TYMP—pancreatic cancer	1.1e-05	0.000214	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—AKT1—pancreatic cancer	1.07e-05	0.000209	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.06e-05	0.000207	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GLP1R—pancreatic cancer	1.05e-05	0.000204	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GLP1R—pancreatic cancer	1.04e-05	0.000202	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PIK3CA—pancreatic cancer	1.03e-05	0.000201	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—DPYD—pancreatic cancer	1.03e-05	0.000201	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—DPYD—pancreatic cancer	1.02e-05	0.000199	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TP53—pancreatic cancer	9.97e-06	0.000194	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	9.76e-06	0.00019	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ARG2—pancreatic cancer	9.7e-06	0.000189	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	9.67e-06	0.000189	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.57e-06	0.000187	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HRAS—pancreatic cancer	9.53e-06	0.000186	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.24e-06	0.00018	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.07e-06	0.000177	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GLP1R—pancreatic cancer	8.85e-06	0.000173	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—DPYD—pancreatic cancer	8.71e-06	0.00017	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TYMP—pancreatic cancer	8.48e-06	0.000165	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—AKT1—pancreatic cancer	8.42e-06	0.000164	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.42e-06	0.000164	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	8.27e-06	0.000161	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.18e-06	0.00016	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.9e-06	0.000154	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CD44—pancreatic cancer	7.56e-06	0.000147	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CD44—pancreatic cancer	7.49e-06	0.000146	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.34e-06	0.000143	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.27e-06	0.000142	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GCG—pancreatic cancer	7.25e-06	0.000141	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.19e-06	0.00014	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GCG—pancreatic cancer	7.18e-06	0.00014	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GLP1R—pancreatic cancer	6.83e-06	0.000133	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—STK11—pancreatic cancer	6.81e-06	0.000133	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—STK11—pancreatic cancer	6.75e-06	0.000132	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—DPYD—pancreatic cancer	6.72e-06	0.000131	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CD44—pancreatic cancer	6.4e-06	0.000125	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	6.38e-06	0.000124	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.34e-06	0.000124	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.27e-06	0.000122	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.21e-06	0.000121	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GCG—pancreatic cancer	6.14e-06	0.00012	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—TYMS—pancreatic cancer	5.86e-06	0.000114	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—TYMS—pancreatic cancer	5.81e-06	0.000113	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—STK11—pancreatic cancer	5.77e-06	0.000113	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.42e-06	0.000106	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TYMS—pancreatic cancer	4.96e-06	9.68e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CD44—pancreatic cancer	4.94e-06	9.64e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—APOE—pancreatic cancer	4.77e-06	9.29e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GCG—pancreatic cancer	4.74e-06	9.24e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—APOE—pancreatic cancer	4.72e-06	9.21e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.47e-06	8.72e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—STK11—pancreatic cancer	4.45e-06	8.69e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	4.3e-06	8.39e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	4.26e-06	8.32e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PPARG—pancreatic cancer	4.15e-06	8.1e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PPARG—pancreatic cancer	4.11e-06	8.03e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—APOE—pancreatic cancer	4.04e-06	7.87e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.83e-06	7.47e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.82e-06	7.45e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.78e-06	7.37e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.75e-06	7.31e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	3.64e-06	7.11e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PPARG—pancreatic cancer	3.52e-06	6.86e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	3.3e-06	6.43e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	3.27e-06	6.37e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTGS2—pancreatic cancer	3.27e-06	6.37e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTGS2—pancreatic cancer	3.24e-06	6.31e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	3.2e-06	6.25e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—APOE—pancreatic cancer	3.12e-06	6.08e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.85e-06	5.55e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.82e-06	5.51e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.81e-06	5.48e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	2.79e-06	5.44e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTGS2—pancreatic cancer	2.77e-06	5.4e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.71e-06	5.29e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.47e-06	4.82e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTEN—pancreatic cancer	2.41e-06	4.71e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.15e-06	4.2e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.13e-06	4.16e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	2.01e-06	3.92e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.99e-06	3.88e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.86e-06	3.63e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.7e-06	3.32e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.64e-06	3.2e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.63e-06	3.17e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.39e-06	2.71e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.31e-06	2.56e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.07e-06	2.09e-05	CbGpPWpGaD
